SPHK1 and rheumatoid arthritis: To this end, and in a murine model of collagen-induced RA, the pharmacological or siRNA knockdown of SPHK1 significantly reduced release of the inflammatory cytokines TNFα, IL-6, IL-1β, MCP1, and MMP9 in vitro [194].